Phase 1/2 Study of ABO-101 in Primary Hyperoxaluria Type 1 (redePHine)

Clinical trial NCT06839235 · RECRUITING

Trial details

NCT number: NCT06839235
Sponsor: Arbor Biotechnologies
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Primary Hyperoxaluria Type 1 (PH1)

Start date: 2025-06-16
Primary completion: 2029-03-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.